Aquarius Surgical Technologies Inc.
AQQRF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.00 | -0.02 | 0.00 |
| FCF Yield | -26.46% | -41.20% | -95.59% | -64.71% |
| EV / EBITDA | 8.22 | -16.48 | -29.70 | -33.39 |
| Quality | ||||
| ROIC | -5.66% | -11.91% | 24.29% | 16.92% |
| Gross Margin | 54.26% | 60.92% | 47.78% | 52.72% |
| Cash Conversion Ratio | -0.06 | 0.14 | 0.65 | 0.46 |
| Growth | ||||
| Revenue 3-Year CAGR | -17.85% | -23.50% | -23.00% | -16.17% |
| Free Cash Flow Growth | 39.28% | 56.88% | -57.04% | -88.68% |
| Safety | ||||
| Net Debt / EBITDA | 8.03 | -16.06 | -28.65 | -32.20 |
| Interest Coverage | -0.86 | -1.16 | -2.37 | -1.66 |
| Efficiency | ||||
| Inventory Turnover | 0.40 | 0.31 | 0.34 | 1.02 |
| Cash Conversion Cycle | 375.81 | -17,527.69 | -14,704.14 | -582.36 |